NCT00572260 - A Pilot Study of Daptomycin for Antimicrobial Prophylaxis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions

Antimicrobial Prophylaxis

Interventions

DRUG

daptomycin 6 mg/kg IV

daptomycin 6 mg/kg IV given during induction phase as a one-time prophylactic dose for patients undergoing cardiac valve replacement and coronary artery bypass grafting (CABG) who are at increased risk for infection due to methicillin-resistant Staphylococcus aureus (MRSA)

Trial Locations (1)

27710

Duke University Medical Center, Durham